For example, miR-15 and miR-16 which were discovered earlier negatively regulated B-cell lymphoma 2 (BCL2) at the posttranscriptional level, and their expression was negatively correlated with BCL2 in chronic lymphocytic leukemia (CLL). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.